BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26244785)

  • 1. Comparative Metabolomic and Lipidomic Analysis of Phenotype Stratified Prostate Cells.
    Burch TC; Isaac G; Booher CL; Rhim JS; Rainville P; Langridge J; Baker A; Nyalwidhe JO
    PLoS One; 2015; 10(8):e0134206. PubMed ID: 26244785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial-to-mesenchymal transition involves triacylglycerol accumulation in DU145 prostate cancer cells.
    Dalmau N; Jaumot J; Tauler R; Bedia C
    Mol Biosyst; 2015 Dec; 11(12):3397-406. PubMed ID: 26474270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer.
    Lucarelli G; Rutigliano M; Galleggiante V; Giglio A; Palazzo S; Ferro M; Simone C; Bettocchi C; Battaglia M; Ditonno P
    Expert Rev Mol Diagn; 2015; 15(9):1211-24. PubMed ID: 26174441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate Cancer.
    Ren S; Shao Y; Zhao X; Hong CS; Wang F; Lu X; Li J; Ye G; Yan M; Zhuang Z; Xu C; Xu G; Sun Y
    Mol Cell Proteomics; 2016 Jan; 15(1):154-63. PubMed ID: 26545398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of tissue metabolomics, transcriptomics and immunohistochemistry reveals ERG- and gleason score-specific metabolomic alterations in prostate cancer.
    Meller S; Meyer HA; Bethan B; Dietrich D; Maldonado SG; Lein M; Montani M; Reszka R; Schatz P; Peter E; Stephan C; Jung K; Kamlage B; Kristiansen G
    Oncotarget; 2016 Jan; 7(2):1421-38. PubMed ID: 26623558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism.
    Tamura K; Makino A; Hullin-Matsuda F; Kobayashi T; Furihata M; Chung S; Ashida S; Miki T; Fujioka T; Shuin T; Nakamura Y; Nakagawa H
    Cancer Res; 2009 Oct; 69(20):8133-40. PubMed ID: 19826053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable metastatic potentials correlate with differential plectin and vimentin expression in syngeneic androgen independent prostate cancer cells.
    Burch TC; Watson MT; Nyalwidhe JO
    PLoS One; 2013; 8(5):e65005. PubMed ID: 23717685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between bivariate expression of key oncogenes and metabolic phenotypes of patients with prostate cancer.
    Khodayari Moez E; Pyne S; Dinu I
    Comput Biol Med; 2018 Dec; 103():55-63. PubMed ID: 30340213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipidome and metabolome analysis of fresh tobacco leaves in different geographical regions using liquid chromatography-mass spectrometry.
    Li L; Lu X; Zhao J; Zhang J; Zhao Y; Zhao C; Xu G
    Anal Bioanal Chem; 2015 Jul; 407(17):5009-20. PubMed ID: 25701418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of potential biomarkers in human melanoma cells with different metastatic potential by metabolic and lipidomic profiling.
    Kim HY; Lee H; Kim SH; Jin H; Bae J; Choi HK
    Sci Rep; 2017 Aug; 7(1):8864. PubMed ID: 28821754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic malignant changes and untargeted lipidomic analysis of long-term exposed prostate cancer cells to endocrine disruptors.
    Bedia C; Dalmau N; Jaumot J; Tauler R
    Environ Res; 2015 Jul; 140():18-31. PubMed ID: 25817993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic signatures of aggressive prostate cancer.
    McDunn JE; Li Z; Adam KP; Neri BP; Wolfert RL; Milburn MV; Lotan Y; Wheeler TM
    Prostate; 2013 Oct; 73(14):1547-60. PubMed ID: 23824564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update.
    Lucarelli G; Loizzo D; Ferro M; Rutigliano M; Vartolomei MD; Cantiello F; Buonerba C; Di Lorenzo G; Terracciano D; De Cobelli O; Bettocchi C; Ditonno P; Battaglia M
    Expert Rev Mol Diagn; 2019 May; 19(5):377-387. PubMed ID: 30957583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-Pyrroline-5-carboxylate released by prostate Cancer cell inhibit T cell proliferation and function by targeting SHP1/cytochrome c oxidoreductase/ROS Axis.
    Yan Y; Chang L; Tian H; Wang L; Zhang Y; Yang T; Li G; Hu W; Shah K; Chen G; Guo Y
    J Immunother Cancer; 2018 Dec; 6(1):148. PubMed ID: 30545412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative metabolic and lipidomic profiling of human breast cancer cells with different metastatic potentials.
    Kim HY; Lee KM; Kim SH; Kwon YJ; Chun YJ; Choi HK
    Oncotarget; 2016 Oct; 7(41):67111-67128. PubMed ID: 27564096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of D-allose on prostate cancer cell lines: phospholipid profiling by nanoflow liquid chromatography-tandem mass spectrometry.
    Jeong RU; Lim S; Kim MO; Moon MH
    Anal Bioanal Chem; 2011 Aug; 401(2):689-98. PubMed ID: 21633842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
    Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
    Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cells.
    Shafi AA; Putluri V; Arnold JM; Tsouko E; Maity S; Roberts JM; Coarfa C; Frigo DE; Putluri N; Sreekumar A; Weigel NL
    Oncotarget; 2015 Oct; 6(31):31997-2012. PubMed ID: 26378018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene profiling and pathway analysis of neuroendocrine transdifferentiated prostate cancer cells.
    Mori R; Xiong S; Wang Q; Tarabolous C; Shimada H; Panteris E; Danenberg KD; Danenberg PV; Pinski JK
    Prostate; 2009 Jan; 69(1):12-23. PubMed ID: 18814146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential protein synthesis and expression levels in normal and neoplastic human prostate cells and their regulation by type I and II interferons.
    Nagano K; Masters JR; Akpan A; Yang A; Corless S; Wood C; Hastie C; Zvelebil M; Cramer R; Naaby-Hansen S
    Oncogene; 2004 Mar; 23(9):1693-703. PubMed ID: 14647428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.